Pillstats
Rx only · Suspension · Oral

Atovaquone

Brands: Mepron · Atovaquone

20 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
20 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers20 labelers
Packages31
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.214$0.429$0.643$0.857Dec 2025Apr 2026Jun 2026
$0.704
Latest avg · Jun 17, 2026
-3%
Since Dec 17, 2025
20
Active US suppliers
26%
Top-2 supplier share*

Who makes it20 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Kesin Pharma Corporationunknown5SUPPLYING
PAI Holdings, LLC dba PAI Pharmaunknown3SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown2SUPPLYING
GlaxoSmithKline LLCunknown2SUPPLYING
ATLANTIC BIOLOGICALS CORP.unknown2SUPPLYING
Abon Pharmaceuticals, LLCunknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Chartwell Governmental & Specialty RX, LLC.unknown1SUPPLYING
Bionpharma Inc.unknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
A2A Integrated Pharmaceuticalsunknown1SUPPLYING
AvKAREunknown1SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING

+ 5 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.